# Dose Dense TC + Pegfilgrastim Support for Breast Cancer

> **NCT01671319** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 42 (actual)

## Conditions studied

- Female Breast Cancer

## Interventions

- **DRUG:** docetaxel + cyclophosphamide + pegfilgrastim

## Key facts

- **NCT ID:** NCT01671319
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01671319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01671319, "Dose Dense TC + Pegfilgrastim Support for Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01671319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*